March 9, 2026 · Form 4 insider transaction
Gyurci John bought 25,253 shares of MMED at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The option vests 33% on each of March 9, 2028 and March 9, 2029, and 34% on March 9, 2030.